Efficacy of intravascular lithotripsy (IVL) in coronary stenosis with severe calcification: A multicenter systematic review and meta-analysis.
Marios Sagris, Nikolaos Ktenopoulos, Kyriakos Dimitriadis...
https://pubmed.ncbi.nlm.nih.gov/38482928/Actively Recruiting
Led by Nanjing First Hospital, Nanjing Medical University · Updated on 2026-03-10
78
Participants Needed
3
Research Sites
26 weeks
Total Duration
Researchers are evaluating different preparation techniques for severely calcified coronary lesions in patients undergoing percutaneous coronary intervention PCI. The trial compares the effects of a super high-pressure balloon and intravascular lithotripsy IVL on stent expansion and safety. Calcified plaques make stent placement challenging and increase the risk of treatment failure, so finding optimal preparation methods is important. Participants receive PCI guided by intravascular imaging using either the super high-pressure balloon or IVL to prepare the calcified lesions before stent implantation. The super high-pressure balloon is a novel device that can expand uniformly under extreme pressure. IVL uses sonic pressure pulses to fracture calcium plaques within the artery. Both methods are being studied to determine their effectiveness and safety in this setting. During the study, stent expansion is measured using intraprocedural imaging techniques such as optical coherence tomography or intravascular ultrasound. Researchers also monitor major adverse cardiac events within 30 days after the procedure. Participants will be assessed throughout the PCI procedure and followed up to evaluate outcomes. The total participation duration includes the procedure and at least a 30-day safety follow-up.
CONDITIONS
Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions
F
Fei Ye, MD
Y
Yi-fei Wang, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nanjing First Hospital, Nanjing Medical University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of procedure
Participants undergo intravascular imaging-guided PCI and receive lesion preparation using either super high-pressure balloon or intravascular lithotripsy (IVL) as part of the treatment.
1 treatment visit (in-person)
Duration - 30 days
Participants are monitored for safety and efficacy outcomes including assessment of major adverse cardiac events (MACE) within 30 days after the procedure.
1 follow-up visit within 30 days (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Marios Sagris, Nikolaos Ktenopoulos, Kyriakos Dimitriadis...
https://pubmed.ncbi.nlm.nih.gov/38482928/Salvatore Cassese, Fiorenzo Simonetti, Hector Alfonso Alvarez Covarrubias...
https://pubmed.ncbi.nlm.nih.gov/39710352/Tobias Rheude, Sean Fitzgerald, Abdelhakim Allali...
https://pubmed.ncbi.nlm.nih.gov/36137691/Tobias Rheude, Himanshu Rai, Gert Richardt...
https://pubmed.ncbi.nlm.nih.gov/33258774/Nanjing First Hospital, Nanjing Medical University
Lead Sponsor